Clinical trials sponsored by Insmed Incorporated
3
Recruiting trials
4
Conditions studied
Phase breakdown
Phase 3 3
Conditions studied
| Condition | Trials |
|---|---|
| Hypertension | 3 |
| Interstitial Lung Disease | 2 |
| Pulmonary Hypertension | 2 |
| Pulmonary Arterial Hypertension | 1 |
Recruiting trials led by Insmed Incorporated
- A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
- An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Common questions
How many trials is Insmed Incorporated recruiting for?
Insmed Incorporated is the lead sponsor of 3 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.